FI923393A - Heteroarylsubstituerade hydroxylaminderivat - Google Patents

Heteroarylsubstituerade hydroxylaminderivat Download PDF

Info

Publication number
FI923393A
FI923393A FI923393A FI923393A FI923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A
Authority
FI
Finland
Prior art keywords
aryl
lower alkyl
cycloalkyl
carbocyclic
heterocyclic
Prior art date
Application number
FI923393A
Other languages
English (en)
Other versions
FI923393A0 (fi
Inventor
Duzer John H Van
Dennis M Roland
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI923393A0 publication Critical patent/FI923393A0/fi
Publication of FI923393A publication Critical patent/FI923393A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI923393A 1991-07-30 1992-07-27 Heteroarylsubstituerade hydroxylaminderivat FI923393A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73807591A 1991-07-30 1991-07-30

Publications (2)

Publication Number Publication Date
FI923393A0 FI923393A0 (fi) 1992-07-27
FI923393A true FI923393A (fi) 1993-01-31

Family

ID=24966464

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923393A FI923393A (fi) 1991-07-30 1992-07-27 Heteroarylsubstituerade hydroxylaminderivat

Country Status (21)

Country Link
EP (1) EP0526402B1 (fi)
JP (1) JPH0641104A (fi)
KR (1) KR930002329A (fi)
AT (1) ATE162525T1 (fi)
AU (1) AU662339B2 (fi)
CA (1) CA2074797A1 (fi)
CZ (1) CZ235192A3 (fi)
DE (1) DE69224115T2 (fi)
DK (1) DK0526402T3 (fi)
ES (1) ES2111059T3 (fi)
FI (1) FI923393A (fi)
GR (1) GR3026254T3 (fi)
HU (1) HUT66626A (fi)
IE (1) IE922471A1 (fi)
IL (1) IL102612A (fi)
MX (1) MX9204418A (fi)
NO (1) NO178925C (fi)
NZ (1) NZ243752A (fi)
PH (1) PH30092A (fi)
TW (1) TW281672B (fi)
ZA (1) ZA925688B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US5516789A (en) * 1995-04-12 1996-05-14 Abbott Laboratories Lipoxygenase and cyclooxygenase inhibiting compounds
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
BR9916565A (pt) 1998-12-23 2002-01-29 Searle Llc Combinações de inibidores do transporte ácido da bile ileal e derivados do ácido fìbrico para indicações cardiovasculares
US6569905B1 (en) 1998-12-23 2003-05-27 G.D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
PT1140184E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com derivados de acido nicotinico para indicacoes cardiovasculares
CA2356422C (en) 1998-12-23 2008-09-16 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
ATE242009T1 (de) 1998-12-23 2003-06-15 Searle Llc Kombinationen von cholesteryl ester transfer protein inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
IL143943A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
EP1286984A2 (en) 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
DE10103506A1 (de) * 2001-01-26 2002-08-14 Ingo S Neu Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose
CA2464685A1 (en) 2001-11-02 2003-05-15 G.D. Searle Llc Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
ES2361924T3 (es) 2002-12-20 2011-06-24 X-Ceptor Therapeutics, Inc. Derivados de isoquinolinona y su uso como agentes terapéuticos.
EP3509588B1 (en) 2016-09-12 2023-06-07 Integral Health,Inc. Bicyclic compounds useful as gpr120 modulators
US10800773B2 (en) 2016-09-12 2020-10-13 Integral Health, Inc. Monocyclic compounds useful as GPR120 modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196184B1 (en) * 1985-03-16 1992-09-16 The Wellcome Foundation Limited Aryl derivatives
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents

Also Published As

Publication number Publication date
EP0526402A1 (en) 1993-02-03
KR930002329A (ko) 1993-02-23
TW281672B (fi) 1996-07-21
CA2074797A1 (en) 1993-01-31
NO178925C (no) 1996-07-03
GR3026254T3 (en) 1998-05-29
PH30092A (en) 1996-12-27
ES2111059T3 (es) 1998-03-01
NZ243752A (en) 1994-09-27
MX9204418A (es) 1993-02-01
EP0526402B1 (en) 1998-01-21
NO922987D0 (no) 1992-07-29
IE922471A1 (en) 1993-02-10
FI923393A0 (fi) 1992-07-27
CZ235192A3 (en) 1993-10-13
ATE162525T1 (de) 1998-02-15
NO922987L (no) 1993-02-01
JPH0641104A (ja) 1994-02-15
HUT66626A (en) 1994-12-28
AU662339B2 (en) 1995-08-31
DE69224115T2 (de) 1998-08-20
IL102612A (en) 1996-11-14
IL102612A0 (en) 1993-01-14
DK0526402T3 (da) 1998-09-14
NO178925B (no) 1996-03-25
ZA925688B (en) 1993-03-31
AU2048292A (en) 1993-02-04
DE69224115D1 (de) 1998-02-26
HU9202479D0 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
FI923393A (fi) Heteroarylsubstituerade hydroxylaminderivat
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DK1022272T3 (da) Substituerede, fusionerede, heterocykliske forbindelser
DK1424330T3 (da) Aktivator for peroxisom proliferator-responsiv receptor delta
ATE542805T1 (de) Ppar-delta aktivatoren
FI921327A (fi) Nya azadekalinamider och tioamider som inhibitorer av kolesterolbiosyntes
DE60223904D1 (de) Benzylaminanalogen
DE69734952D1 (de) Anilide als ACAT-Hemmer
BR9200057A (pt) Composto e composicao farmaceutica
DE60100207D1 (de) Verfahren zu Synthese von N-(mercaptoacyl)-aminosäure Derivaten von alfasubstituierte Acrylsäuren an
DE69911946D1 (de) Phosphonsäure-diester-derivate
NZ337142A (en) Hydroxamic acid compounds
EP1069115A4 (en) METHOD FOR PRODUCING OXAZOLIDIN-2-ONE COMPOUNDS
BR8003950A (pt) Composicoes herbicidas, baseadas em derivados de m-anilido-uretana
DK1078916T3 (da) Fremgangsmåde til fremstilling af N-acylaminosyreestere og N-acylaminoacetaler

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed